Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system

Clinical Cancer Research

Volumn 3, Issue 3, 1997, Pages 473-478

  Biegel, Jaclyn A ^a   Janss, Anna J ^a   Raffel, Corey ^b   Sutton, Leslie ^a   Rorke, Lucy B ^a   Harper, James M ^c   Phillips, Peter C ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b MAYO CLINIC   (United States)

^c Strategic Development Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CHROMOSOME 17P; CHROMOSOME DELETION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MULTIVARIATE ANALYSIS; NEUROECTODERM TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; TUMOR BIOPSY;

AGE FACTORS; BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUROECTODERMAL TUMORS, PRIMITIVE; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0030988932     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Allen, J. C.,and Epstein, F. Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS. J. Neurosurg.,57: 446-451, 1982.
2. Evans, A. E.,Jenkin, R. D. T.,Sposto, R.,Oretega, J. A.,Wilson, C. B.,Wara, W.,Ertel, I. J.,Kramer, S.,Chang, C. H.,Leikin, S. L.,and Hammond, G. D. The treatment of medulloblastoma: results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J. Neurosurg.,72: 572-582, 1990.
3. Carton, G. R.,Schomberg, P. J.,Scheithauer, B. W.,Shaw, E. G.,Blackwell, C. R.,Laws, E. R.,Jr.,and Earlie, J. D. Medulloblastoma prognostic factors and outcome of treatment: review of the Mayo clinic experience. Mayo Clin. Proc.,65:1077-1086, 1990.
4. Packer, R. J.,Sutton, L. N.,Elterman, R.,Lange, B.,Goldwein, J.,Nicholson, H. S.,Mulne, L.,Boyett, J.,D'Angio, G.,Weschler-Jentzsch, K.,Reaman, G.,Cohen, B.,Bruce, D. A.,Rorke, L. B.,Molloy, P.,Tynan, J.,LaFond, D.,Evans, A. E.,and Schut, L. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J. Neurosurg.,18:690-698, 1994.
5. Goldwein, J. W.,Radcliffe, J.,Packer, R. J.,Sutton, L. N.,Lange, B.,Rorke, L. B.,and D'Angio, G. J. Results of a pilot study of low-dose craniospinal radiation therapy plus chemotherapy for children younger than 5 years with primitive neuroectodermal tumors. Cancer (Phila.), 71:2647-2652, 1993.
6. Brodeur, G. M. Neuroblastoma: clinical significance of genetic abnormalities. Cancer Surv.,9: 673-688, 1990.
7. Maris, J. M.,White, P. S.,Beltinger, C. P.,Sulman, E. P.,Castleberry, R. P.,Shuster, J. J.,Look, A. T.,and Brodeur, G. M. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res.,55: 4664-4669, 1995.
8. Caputy, A. J.,McCullough, D. C.,Manz, H. J.,Patterson, K.,and Hamnmock, M. K. A review of the factors influencing the prognosis of medulloblastoma: the importance of cell differentiation. J. Neurosurg.,66:80-87, 1987.
9. Packer, R. J.,Sutton, L. N.,Rorke, L. B.,Littman, P. A.,Sposto, R.,Rosenstock, J. G.,Bruce, D. A.,and Schut, L. Prognostic importance of cellular differentiation in medulloblastoma in children. J. Neurosurg.,61:296-301, 1984.
10. Czerwionka, M.,Korf, H. W.,Hoffmann, O.,Busch, H.,and Schachenmayr, W. Differentiation in medulloblastomas: correlation between the immunocytochemical demonstration of photoreceptor markers (S-antigen, rod-opsin) and the survival in 66 patients. Acta Neuropathol.,78:629-636, 1989.
11. Gajjar, A.,Heideman, R.,Douglass, E.,Kun, L. E.,Kovnar, E. H.,Sanford, R. A.,Fairlough, D. L.,Ayers, D.,and Look, A. T. Relation of tumor cell ploidy to survival in children with medulloblastoma. J. Clin. Oncol.,11:2211-2217, 1993.
12. Janss, A. J.,Yachnis, A. T.,Silber, J. H.,Trojanowski, J. Q.,Lee, V. M-Y.,Sutton, L.,Perilongo, G.,Rorke, L. B.,and Phillips, P. C. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors. Ann. Neurol.,39:481-489, 1996.
13. Tomita, T.,Yasue, M.,Engelhard, H. H.,McLone, D. G.,Gonzalez-Crussi, F.,and Bauer, K. D. Flow cytometric DNA analysis of medulloblastoma: prognostic implication of aneuploidy. Cancer (Phila.), 61:744-749, 1988.
14. Zerbini, C.,Gelber, R.,Weinberg, D.,Sallan, S. E.,Barnes, P.,Kupsky, W.,Scott, R. M.,and Tarbell, N. J. Prognostic factors in medulloblastoma, including DNA ploidy. J. Clin. Oncol.,11: 616-622, 1993.
15. Segal, R. A.,Goumnerova, L. C.,Kwon, Y. K.,Stiles, C. D.,and Pomeroy, S. L. Expression of the neurotrophin receptor trkC linked to a favorable outcome in medulloblastoma. Proc. Natl. Acad. Sci. USA, 91:12867-12871, 1994.
16. Batra, S. K.,McLendon, R. E.,Koo, J. S.,Castelino-Prabhu, S.,Fuchs, H. E.,Krischer, J. P.,Friedman, H.,Bigner, D. O.,and Bigner, S. H. Prognostic implications of chromosome 17p deletions in human medulloblastomas. J. Neuro-oncol.,24:39-45, 1995.
17. Cogen, P. H. Prognostic significance of molecular genetic markers in childhood brain tumors. Pediatr. Neurosurg.,92:245-250, 1991.
18. Cogen, P. H.,Daneshvar, L.,Metzger, A. K.,Duyk, G.,Edwards, M. S. B.,and Sheffield, V. C. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am. J. Hum. Genet.,50:584-589, 1992.
19. Cogen, P. H.,Daneshvar, L.,Metzger, A. K.,and Edwards, M. S. B. Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics, 8:279-285, 1990.
20. Chang, C. H.,Housepian, E. M.,Jr.,and Herbert, C. An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastomas. Radiology, 93:1351-1359, 1969.
21. Thomas, G. A.,and Raffel, C. Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res.,51: 639-643, 1991.
22. Griffin, C. A.,Hawkins, A. L.,Packer, R. J.,Rorke, L. B.,and Emanuel, B. S. Chromosome abnormalities in pediatric brain tumors. Cancer Res.,48:175-180, 1988.
23. Biegel, J.,Rorke, L. B.,Packer, R. J.,Sutton, L. N.,Schut, L.,Bonner, K.,and Emanuel, B. S. Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes & Cancer, 1:139-147, 1989.
24. Biegel, J. A.,Rorke, L. B.,Janss, A. J.,Sutton, L. N.,and Parmiter, A. H. Isochromosome 17q demonstrated by interphase FISH in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes & Cancer, 14:85-96, 1995.
25. Biegel, J.,Burk, C.,Barr, F.,and Emanuel B. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res.,52:3391-3395, 1992.
26. Slave, I.,Rodriguez, I. R.,Mazuruk, K.,Chader, G. J.,and Biegel, J. LOH detected by single-strand conformation polymorphism analysis of PEDF in CNS primitive neuroectodermal tumors. Med. Pediatr. Oncol.,25: P174, 1995.
27. Fleiss, J. L. Statistical Methods for Rates and Proportions, Second Edition. New York: John Wiley and Sons, Inc.,1981.
28. Kalbfleisch, J. D.,and Prentice, R. L. The Statistical Analysis of Failure Time Data, pp. 13-16. New York: John Wiley and Sons, Inc.,1980.
29. Kalbfleisch, J. D.,and Prentice, R. L. The Statistical Analysis of Failure Time Data, pp. 70-142. New York: John Wiley and Sons, Inc.,1980.
30. Lachin, J. M. Introduction to sample size determination and power analysis for clinical trials. Controlled Clin. Trials, 2: 93-113, 1981.
31. Duffner, P. K.,Horowitz, M. E.,Krischer, J. P.,Friedman, H. S.,Burger, P. C.,Cohen, M. E.,Sanford, R. A.,Mulhern, R. K.,James, H. E.,and Freeman, C. R. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N. Engl. J. Med.,328:1780-1781, 1993.
32. Pendergrass, T. W.,Milstein, J. M.,Geyer, J. R.,Mulne, A. F.,Kosnik, E. J.,Morris, J. D.,Heideman, R. L.,Ruymann, F. B.,Stuntz, J. T.,and Bleyer, W. A. Eight drugs in one-day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. J. Clin. Oncol.,5: 1221-1231, 1987.
33. Rorke, L. B.,Packer, R.,and Biegel, J. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J. Neurooncol.,24:21-28, 1995.
34. Cohen, B. H.,Zeltzer, P. M.,Boyett, J. M.,Geyer, J. R.,Allen, J. C.,Finlay, J. L.,McGuire-Cullen, P.,Milstein, J. M.,Rorke, L. B.,and Stanley, D. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Children's Cancer Group randomized trial. J. Clin. Oncol.,13:1687-1696, 1995.
35. Gajjar, A.,Mulhern, R. K.,Heideman, R. L.,Sanford, R. A.,Douglass, E. C.,Kovnar, E. H.,Langston, J. A.,Jenkins, J. J.,and Kun, L. E. Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J. Clin. Oncol.,12:1212-1216, 1994.
36. Kopelson, G.,Linggood, R. M.,and Kleinman, G. M. Medulloblastoma: identification of prognostic subgroups and implications for multimodal management. Cancer (Phila.), 51: 312-319, 1983.
37. Tait, D. M.,Thornton-Jones, H.,Bloom, H. J. G.,Lemerle, J.,and Morris-Jones, P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology. Eur. J. Cancer, 26:464-469, 1990.
38. Felix, C. A.,Slave, I.,Dunn, M.,Strauss, E. A.,and Biegel, J. A. p53 gene mutations in pediatric brain tumors. Med. Pediatr. Oncol.,25: 431-436, 1995.
39. Raffel, C.,Thomas, G. A.,Tishler, D. M.,Lassoff, S.,and Allen, J. C. Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors. Neurosurgery (Baltimore), 33:301-306, 1993.
40. Emadian, S. M.,McDonald, J. D.,Gerken, S. C.,and Fults, D. Correlation of chromosome 17p loss with clinical outcome in medullo-blastoma. Clin. Cancer Res.,2: 1559-1564, 1996.